Table 4 Multivariate analysis of the prognostic factors for survival
From: Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma
clinicopathological characteristics | OS (month) | DFS (month) | ||||
|---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | |
SCS grade | 3.012 | 1.001–9.059 | 0.049 | 2.626 | 1.224–5.637 | 0.013 |
Silva system | 0.359 | 0.031–4.107 | 0.410 | 0.805 | 0.160–4.039 | 0.792 |
LNM | 1.462 | 0.181–11.791 | 0.721 | 2.041 | 0.853–4.880 | 0.109 |
FIGO stage | 1.883 | 1.067–3.325 | 0.029 | 1.072 | 0.364–3.158 | 0.900 |
DOI | 1.919 | 0.510–7.219 | 0.335 | 1.382 | 0.509–3.753 | 0.525 |